Article
NP-59 Adrenal Scintigraphy as an Imaging Biomarker to Predict KCNJ5 Mutation in Primary Aldosteronism Patients.
Frontiers in endocrinology - 1 Jan 2021
Lu Ching-Chu, Yen Ruoh-Fang, Peng Kang-Yung, Huang Jei-Yie, Wu Kwan-Dun, Chueh Jeff S, Lin Wan-Yu
Abstract excerpt
Purpose: Somatic KCNJ5 mutation occurs in half of unilateral primary aldosteronism (PA) and is associated with more severe phenotype. Mutation status can only be identified by tissue sample from adrenalectomy. NP-59 adrenal scintigraphy is a noninvasive functional study for disease activity assessment. This study aimed to evaluate the predictive value of NP-59 adrenal scintigraphy in somatic KCNJ5 mutation among...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
